{"id":"tp-41894","type":"article-newspaper","title":"GSK’s Clinical-Stage Oncology Portfolio Could Nearly Double in 2027","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/41894","datePublished":"2026-10-27T17:30:06.000Z","dateModified":"2026-10-27T17:30:06.000Z","language":"en","abstract":"Oncology chief Hesham Abdullah said GSK could have 19 to 20 late-stage studies underway that year. He put the current portfolio at about 15 assets.","section":"Business","references":[]}